• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tiziana Life Sciences Ltd - Common Shares (NQ:TLSA)

    1.260 +0.030 (+2.44%)
    Streaming Delayed Price Updated: 10:16 AM EDT, Jun 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Tiziana Life Sciences Ltd - Common Shares

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    News headline image
    Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Neurology-Focused Tiziana Life Confirms Discovery In Multiple Sclerosis Therapy Study ↗
    Tiziana Life Sciences recently discovered new immune biomarkers in SPMS patients treated with nasal foralumab. 
    Via Benzinga
    News headline image
    Tiziana Life Sciences not to engage in capital raising activities for the immediate future
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus ↗
    U.S. stock futures were higher on Friday, the slipping in first trading session of 2025. All four index futures advanced in premarket trade. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Elon Musk Says Amazon Founder Jeff Bezos Urged Tesla, SpaceX Investors To Dump Stakes, Predicting Trump's Loss ↗
    Tesla Inc (NASDAQ: TLSA) and SpaceX, chief executive officer, Elon Musk sparked a new controversy by saying that Jeff Bezos, the founder and executive chairman of Amazon.com, predicted President-elect... 
    Via Benzinga
    Topics Government
    News headline image
    Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Cathie Wood Redirects Elon Musk's DOGE Focus Toward Nuclear Energy Amid Regulatory Challenges: Here's How Oklo, Cameco, Centrus Energy And Other Stocks Performed ↗
    Nuclear energy stocks and ETFs have come to the fore as ARK Invest's founder Cathie Wood reshared the firm's study on how regulatory hurdles and anti-nuclear sentiment have caused cost overruns and... 
    Via Benzinga
    Topics ETFs Energy
    News headline image
    Donald Trump Gives Tesla Wings For 27% Rally Since Presidential Election ↗
    The EV giant received a substantial price target hike Monday, suggesting 24% upside. 
    Via Investor's Business Daily
    Topics Government
    News headline image
    Tesla Reclaims $1 Trillion Market Cap For First Time Since 2022 In Huge Trump Run ↗
    Tesla stock is on pace for its best weekly performance since January 2023. 
    Via Investor's Business Daily
    Topics Government
    News headline image
    Tesla Surges To 15-Month High On Election; Musk-Trump Alliance In Focus ↗
    Tesla stock is set to hit a 15-month high. 
    Via Investor's Business Daily
    News headline image
    Cathie Wood Sells Tesla Before Election; Musk Cabinet Position "Not What Shareholders Want To See" ↗
    Tesla stock flashed a sell signal Monday and is well below a traditional buy point. 
    Via Investor's Business Daily
    News headline image
    Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
    Includes initial funding of approximately $5 million, as well as the option for additional proceeds of approximately $5 million 
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building ↗
    Consumer support for robotaxis is low for people who have not been inside a self-driving vehicle or live in a city where the vehicles operate. 
    Via Benzinga
    News headline image
    Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    News headline image
    Tiziana Life Sciences Appoints New Chief Executive Officer
    From Tiziana Life Sciences Ltd.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.